Amedisys Sees Unusually Large Options Volume (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) was the recipient of unusually large options trading activity on Friday. Stock traders bought 3,269 put options on the company. This is an increase of 136% compared to the typical volume of 1,385 put options.

Amedisys Price Performance

NASDAQ:AMED opened at $89.96 on Friday. The firm’s fifty day moving average price is $90.45 and its two-hundred day moving average price is $94.43. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company has a market cap of $2.95 billion, a P/E ratio of 35.70, a P/E/G ratio of 1.84 and a beta of 0.73. Amedisys has a one year low of $82.15 and a one year high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.98 earnings per share. Equities analysts expect that Amedisys will post 4.45 earnings per share for the current year.

Hedge Funds Weigh In On Amedisys

A number of large investors have recently made changes to their positions in AMED. KBC Group NV acquired a new stake in Amedisys in the 3rd quarter worth about $63,000. Innealta Capital LLC bought a new position in shares of Amedisys during the second quarter worth approximately $64,000. Signaturefd LLC raised its position in shares of Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after buying an additional 530 shares in the last quarter. CWM LLC boosted its stake in shares of Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after buying an additional 277 shares during the period. Finally, Crossmark Global Holdings Inc. acquired a new stake in Amedisys during the third quarter worth approximately $243,000. Institutional investors own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.